Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A New York man has filed an Invokana side effects lawsuit, alleging that the diabetes medication caused him “catastrophic personal injuries.”
Plaintiff Bruce G. filed the Invokana lawsuit against Janssen Pharmaceuticals, Johnson & Johnson, and several other companies involved in the manufacture of the drug. According to the Invokana lawsuit, Bruce suffered from his injuries on April 22, 2015 as a result of taking Invokana.
Though Bruce’s Invokana lawsuit does not detail his exact injuries, the Food and Drug Administration (FDA) released a Drug Safety Communication in May 2015, stating that the class of diabetes medications that includes Invoakana may increase the risk of a condition called ketoacidosis.
The FDA based the communication on a search of their Adverse Event Reporting System, which found over twenty emergency cases identified as diabetic ketoacidosis or similar events in patients taking Invokana or related drugs.
Diabetic Ketoacidosis
According to the Mayo Clinic, diabetic ketoacidosis is a serious disorder that develops quickly, in some cases in as little as 24 hours from the time that the first symptoms appear.
The symptoms of diabetic ketoacidosis includes extreme thirst, frequent urination, nausea and vomiting, stomach and abdomen pain, fatigue, shortness of breath, and a fruity scent to the breath.
Curiously, this last symptom is caused by the excessive ketones themselves. These organic compounds are actually used by chemists to create fruit scents and flavors, though the bodies of diabetics can produce high levels of these compounds.
Diabetic ketoacidosis can be a naturally-occurring diabetes complication, but it is most common when diabetes is untreated or undiagnosed. It is most common in type-1 diabetes, but can occur in patients with type-2 diabetes. Invokana is only approved for use in patients with type-2 diabetes.
Bruce’s Invokana lawsuit alleges that the makers of diabetes medications were aware — or reasonably should have been aware — of the risk of Invokana side effects.
The Invokana lawsuit states that the drug was “defective” and that it was “fraudulent” to sell the drug to patients like Bruce. The Invokana lawsuit seeks to recoup the cost of Bruce’s medical care and other costs stemming from alleged Invokana side effects.
The Invokana Side Effects Lawsuit is Case No. 1:15-cv-06401-FB-VMS, filed in the United States District Court for the Eastern District of New York.
In general, diabetes medication lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Diabetes Medication Class Action Lawsuit Investigation
If you or a loved one suffered ketoacidosis or kidney failure after taking Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance or Glyxambi, you may have a legal claim. See if you qualify to pursue compensation and join a free diabetes medication class action lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
Oops! We could not locate your form.
